Glipizide Tablet
Product Images NDC 62559-315

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Glipizide (NDC 62559-315). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ani Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Image 01)

Chemical structure of Glipizide depicted as a line drawing showing the molecular framework with labeled functional groups including sulfonylurea moiety and cyclohexyl ring.*

FDA Label Image

Logo (Image 02)

FDA Label Image

Image 03

Glipizide Tablets USP 5 mg label showing a bottle containing 1000 tablets. The label includes the drug strength (5 mg), manufacturer ANI Pharmaceuticals Canada, Inc., and distributor ANI Pharmaceuticals, Inc. Storage instructions and regulatory information are also visible, along with the NDC 62559-315-10 barcode.*

FDA Label Image

Label-10mg (Image 04)

Label for Glipizide Tablets USP 10 mg, an oral prescription tablet. The label shows the NDC 62559-316-10 and states the quantity as 1000 tablets. It is manufactured by ANI Pharmaceuticals Canada, Inc. and distributed by ANI Pharmaceuticals, Inc. The label includes storage instructions, dosage information advising to see the package insert, and warnings to keep out of reach of children.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.